Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary EDAP-TMS to Announce Second Quarter 2017 Financial Results on Wednesday, August 23, 2017
PRESS RELEASE Contact: Blandine Confort Investor Relations / Legal Affairs EDAP TMS SA +33 4 72 15 31 72 bconfort@edap-tms.com Investors: Rich Cockrell CG CAPITAL 877.889.1972 rich@cg.capital   EDAP-TMS to Announce Second Quarter 2017 Financial Results on Wednesday, August 23, 2017 Conference Call
View HTML
Toggle Summary EDAP's New Sonolith i-move Lithotripter Receives Best 2010 Product Innovation Award
LYON, France , Nov. 23, 2010 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today that its new lithotripter Sonolith i-move received the Best 2010 Product Innovation award by the French economic journal Bref Rhone-Alpes .
View HTML
Toggle Summary EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation
EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center of Excellence by the Focused Ultrasound Foundation LYON, France, March 8, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that the prestigious Focused Ultrasound Foundation,
View HTML
Toggle Summary EDAP's HIFU Technology Highlighted At Three Prestigious U.S. Medical Conferences
EDAP's HIFU Technology Highlighted At Three Prestigious U.S. Medical Conferences LYON, France, Feb. 15, 2008 (PRIME NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Ablatherm ® -HIFU was featured in presentations at three major U.S.
View HTML
Toggle Summary EDAP's HIFU Technology Highlighted At the 8th Annual International Symposium On Therapeutic Ultrasound
LYON, France, Sep 15, 2008 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its High Intensity Focused Ultrasound (HIFU) technology was highlighted at the 8th Annual International Symposium on Therapeutic
View HTML
Toggle Summary EDAP's HIFU Technology Highlighted at 12th International Symposium on Therapeutic Ultrasound
Data Describe HIFU as Therapy for Prostate and Liver Cancer
View HTML
Toggle Summary EDAP's HIFU and Lithotripsy Devices Highlighted at 29th Annual EAU Congress
LYON, France , April 10, 2014 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its participation at the European Association of Urology (EAU) 2014 Annual Congress that will be held in Stockholm on April 11-15, 2014 .
View HTML
Toggle Summary EDAP's Focal One® Robotic HIFU Treatments Performed at Acibadem Hospital, Istanbul, Turkey
  LYON, France , December 18, 2017 -- EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced the first HIFU treatments performed at Acibadem Hospital , Istanbul, Turkey , using the Company's Focal One Robotic HIFU device.   Prof.
View HTML
Toggle Summary EDAP's Focal One(R) HIFU Device Adopted by Two University Hospitals in Switzerland
Growing Interest in Europe for HIFU Focal Approach in the Management of Prostate Cancer
View HTML
Toggle Summary EDAP's Focal One HIFU Device Approved by Health Canada
LYON, France , Jan. 9, 2015 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that its Focal One HIFU device has been approved by Health Canada . With this approval, the Company is able to market the Focal One device for the treatment of
View HTML